# Foresight Biotherapeutics, Inc. — Form D

Foresight Biotherapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-13. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-11-13
- Form: D
- Accession: 0001526947-13-000003
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $15.0M
- Amount sold: $15.0M
- Minimum investment: $15.0M
- Investors: 2
- Date of first sale: 2013-10-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-206282

## Issuer

- Name: Foresight Biotherapeutics, Inc.
- CIK: 0001526947
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 50 WEST 57TH STREET, NEW YORK, NY, 10019
- Phone: 6467479100

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Rocamboli | Director | New York, NY |
| Jason Stein | Director | New York, NY |
| Michael Weiser | Director | Los Angles, CA |
| Jason Stein | Executive Officer | New York, NY |
| Michael Weiser | Executive Officer | Los Angles, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2011-07-29](https://search.stillhousedata.com/formd/0001526947-11-000001) | D | $2.0M | $2.0M |

## More

- [CIK 1526947 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1526947&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001526947-13-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.